AI is not just for the drug development phase of pharmaceutical manufacturing. Now is the time for the business side to leverage it.

New medicines save lives, but they take too long to get to market. Could AI make a difference?

Cell and Gene therapies have come a long way since the 1970s. Technology, combined with knowledge, will take them even further.

Pharma companies are well accustomed to supply chain issues, but how prepared are they for issues impacting access to medical devices?

As 2024 draws to its conclusion, two experts look at trends in clinical trials and form predictions for 2025.

AI, the Inflation Reduction Act, and a surge in precision medicine; experts look at pharma’s future.

AI solutions can help sift through clinical trial data for effective medical writing, but more people need to use it.

Immunotherapies can accomplish much, but we can only unlock their true power through collaboration.

Experts share their insights on the disruptive trends reshaping healthcare, including the rise of personalized medicine and digital innovation.